<code id='1BE507BA1E'></code><style id='1BE507BA1E'></style>
    • <acronym id='1BE507BA1E'></acronym>
      <center id='1BE507BA1E'><center id='1BE507BA1E'><tfoot id='1BE507BA1E'></tfoot></center><abbr id='1BE507BA1E'><dir id='1BE507BA1E'><tfoot id='1BE507BA1E'></tfoot><noframes id='1BE507BA1E'>

    • <optgroup id='1BE507BA1E'><strike id='1BE507BA1E'><sup id='1BE507BA1E'></sup></strike><code id='1BE507BA1E'></code></optgroup>
        1. <b id='1BE507BA1E'><label id='1BE507BA1E'><select id='1BE507BA1E'><dt id='1BE507BA1E'><span id='1BE507BA1E'></span></dt></select></label></b><u id='1BE507BA1E'></u>
          <i id='1BE507BA1E'><strike id='1BE507BA1E'><tt id='1BE507BA1E'><pre id='1BE507BA1E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:26434
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Flagship Pioneering launches a new biotech in two countries
          Flagship Pioneering launches a new biotech in two countries

          AdobeFlagshipPioneering,theventurecapitalfirmbehindModerna,onTuesdayunveiledanewbiotechcalledQuotien

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          ARCH Venture Partners is raising $3 billion for a life sciences fund

          AdobeARCHVenturePartners,oneofthetopinvestorsinthebiotechecosystem,israising$3billionforanewfund.The